Please Wait
Applying Filters...
menu
    • menu
    FDA approvals drop 24% in H1 2025; GSK’s UTI med, Vertex’s non-opioid painkiller lead pack of first-in-class meds

    Data Compilation
    #PharmaFlow

    Pipeline Prospector July 2025: Merck to acquire Verona for US$ 10 bn; FDA okays Regeneron’s blood cancer med

    Stock Recap
    #PipelineProspector

    Menu

    Alphapharm Brand of Gliclazide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 85Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    28/08/2025 Bal Pharma
    India
    		 BAL PHARMA LIMITED Bengaluru IN CEP 2001-273 - Rev 08 Gliclazide 2025-07-30 Valid Chemical 1524
    28/08/2025 Ami Lifesciences Private Limited
    India
    		 AMI LIFESCIENCES PRIVATE LIMITED Karakhadi IN CEP 2021-465 - Rev 00 Gliclazide 2024-02-15 Valid Chemical 1524